ESSC - ETF AI Analysis

Top Page

Eventide Small Cap ETF (ESSC)

Rating:64Neutral

Price Target:―

The Eventide Small Cap ETF (ESSC) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Strong contributors like Archrock (AROC), with its robust revenue growth, profitability, and attractive dividend yield, and GATX, which benefits from strong financial performance and positive corporate events, help bolster the fund's rating. However, weaker holdings such as Celcuity (CELC), which faces financial challenges and valuation concerns, weigh on the overall score. A key risk factor for the ETF is its exposure to early-stage or financially challenged companies, which may introduce volatility.

Positive Factors

Strong Top Holdings

Several top holdings, such as Celcuity and InterDigital, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Sector Diversification

The ETF is spread across multiple sectors, including Health Care, Technology, and Financials, reducing reliance on any single industry.

Reasonable Expense Ratio

The ETF charges a relatively low expense ratio, making it cost-effective compared to many actively managed funds.

Negative Factors

High Geographic Concentration

The ETF is heavily concentrated in U.S. companies, offering little exposure to international markets.

Lagging Holdings

Some holdings, such as Marcus & Millichap and Archrock, have underperformed, which could drag on overall returns.

Small Asset Base

The fund has relatively low assets under management, which may limit liquidity and scalability for larger investors.

ESSC vs. SPDR S&P 500 ETF (SPY)

AUM8.71M

RegionNorth America

Expense Ratio0.49%

Beta1.07

IssuerEventide

Inception DateSep 29, 2025

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume29,279

30 Day Avg. Volume6,732

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

32.18

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering340

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ESSC Summary

The Eventide Small Cap ETF (ESSC) is an actively managed fund that invests in small U.S. companies with strong growth potential, while also focusing on ethical principles inspired by the Christian faith. It includes businesses from various sectors like health care, technology, and financials, with top holdings such as Element Solutions and Marcus & Millichap. Investors might consider ESSC for its focus on small-cap stocks and its values-driven approach, which combines financial growth with positive societal impact. However, new investors should be aware that small-cap stocks can be more volatile than larger companies, meaning their prices can rise and fall quickly.

How much will it cost me?The Eventide Small Cap ETF (ESSC) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, requiring more research and oversight to select investments that align with its values-driven approach.

What would affect this ETF?The Eventide Small Cap ETF (ESSC) could benefit from growth in sectors like Health Care and Technology, which make up a significant portion of its holdings, especially if innovation or favorable regulations drive these industries forward. However, small-cap stocks are often more sensitive to economic downturns, interest rate hikes, or market volatility, which could negatively impact the fund's performance. Additionally, its focus on U.S. companies means it could be affected by domestic policy changes or economic conditions more than global trends.

ESSC Top 10 Holdings

The Eventide Small Cap ETF (ESSC) leans heavily into health care, financials, and technology, with these sectors making up over half of its portfolio. Celcuity and Revolution Medicines are rising stars in the biotech space, showing strong momentum despite the typical challenges of early-stage firms. On the other hand, Element Solutions is lagging, with bearish technical signals weighing on its otherwise solid fundamentals. Century Aluminum adds a spark with its positive trend, while F.N.B. provides steady growth and an attractive dividend. Overall, the fund’s U.S.-focused small-cap strategy is a mix of promise and risk, with health care driving much of the action.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
CELC	Celcuity	1.08%	$94.81K	$4.75B	684.48%	44 Neutral
RVMD	Revolution Medicines	0.92%	$80.38K	$15.70B	79.27%	52 Neutral
CENX	Century Aluminum	0.83%	$72.64K	$3.67B	107.00%	61 Neutral
COMP	Compass	0.80%	$70.14K	$6.00B	77.00%	61 Neutral
ESI	Element Solutions	0.77%	$67.05K	$6.22B	-0.46%	65 Neutral
FNB	F.N.B.	0.75%	$65.67K	$6.31B	17.79%	75 Outperform
AROC	Archrock	0.75%	$65.56K	$4.52B	3.95%	79 Outperform
AGX	Argan	0.74%	$65.00K	$4.55B	125.78%	73 Outperform
GATX	GATX	0.72%	$63.22K	$6.22B	10.29%	76 Outperform
ASB	Associated Banc-Corp	0.72%	$63.08K	$4.41B	8.32%	74 Outperform

ESSC Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

25.52

Positive

100DMA

200DMA

Market Momentum

MACD

0.31

Positive

RSI

60.71

Neutral

STOCH

62.91

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ESSC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.20, equal to the 50-day MA of 25.52, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.31 indicates Positive momentum. The RSI at 60.71 is Neutral, neither overbought nor oversold. The STOCH value of 62.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ESSC.

ESSC Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ESSC	―	―	$8.71M	0.49%	―
AFSM	―	―	$67.23M	0.75%	―
FSCC	―	―	$65.20M	0.36%	―
SYZ	―	―	$56.22M	0.74%	―
ALIL	―	―	$21.02M	0.74%	―
SMLL	―	―	$15.74M	0.80%	―

Performance Comparison

ESSC

Eventide Small Cap ETF

26.54

1.47

5.86%

AFSM

First Trust Active Factor Small Cap ETF

―

FSCC

Federated Hermes MDT Small Cap Core ETF

―

SYZ

Lazard US Systematic Small Cap Equity ETF

―

ALIL

Argent Focused Small Cap ETF

―

SMLL

Harbor Active Small Cap ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents